High and Sustained Transgene Expression in Vivo from Plasmid Vectors Containing a Hybrid Ubiquitin Promoter
Open Access
- 1 July 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 4 (1), 75-82
- https://doi.org/10.1006/mthe.2001.0415
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Comprehensive Analysis of the Acute Toxicities Induced by Systemic Administration of Cationic Lipid:Plasmid DNA Complexes in MiceHuman Gene Therapy, 2000
- Ubiquitin-mediated proteolysis: biological regulation via destructionBioEssays, 2000
- Reduced Inflammatory Response to Plasmid DNA Vectors by Elimination and Inhibition of Immunostimulatory CpG MotifsMolecular Therapy, 2000
- The Inhibitory Role of CpG Immunostimulatory Motifs in Cationic Lipid Vector-Mediated Transgene Expression in VivoHuman Gene Therapy, 1999
- Persistent, Therapeutically Relevant Levels of Human Granulocyte Colony-Stimulating Factor in Mice after Systemic Delivery of Adeno-Associated Virus VectorsHuman Gene Therapy, 1999
- Direct Immunologic activities of CpG DNA and implications for gene therapyThe Journal of Gene Medicine, 1999
- Biodistribution and Gene Expression of Lipid/Plasmid Complexes after Systemic AdministrationHuman Gene Therapy, 1998
- Sustained transgene expression in vitro and in vivo using an Epstein–Barr virus replicon vector system combined with HVJ liposomesGene Therapy, 1998
- Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectorsFEBS Letters, 1990
- Partial processing of the neuropeptide Y precursor in transfected CHO cellsFEBS Letters, 1990